Efficacy Assessment and Prognostic Value of Inflammatory Markers in Patients with Stage IV Acral and Cutaneous Melanoma Receiving PD-1 Inhibitors
We established a prognostic predictive model based on distant metastatic sites, NLR, and PNI, and verified its superior performance and potential for clinical application.
Authors
- Hau Xuan Nguyen (ORCID: https://orcid.org/0000-0002-9943-4217)
- Yiyin Zhang (ORCID: https://orcid.org/0000-0002-4887-2401)
- Ziting Qu (ORCID: https://orcid.org/0009-0003-7314-9279)
- Yan Zhang (ORCID: https://orcid.org/0009-0009-9269-6845)
- Kangsheng Gu (ORCID: https://orcid.org/0000-0002-5800-5256)
- Ziran He
- Lili Lu (ORCID: https://orcid.org/0000-0002-0191-1792)
- Cui-Cui Ding (ORCID: https://orcid.org/0000-0002-4785-6629)
Institutions
- Anhui Medical University (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- Second Affiliated Hospital of Anhui Medical University (CN)
Publication Details
- Journal
- Journal of Inflammation Research
- Published
- 2025-02-01
- DOI
- https://doi.org/10.2147/jir.s509928
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Anhui Medical University